180 related articles for article (PubMed ID: 11477961)
1. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia.
Nokes DJ; Enquselassie F; Nigatu W; Vyse AJ; Cohen BJ; Brown DW; Cutts FT
Bull World Health Organ; 2001; 79(7):588-95. PubMed ID: 11477961
[TBL] [Abstract][Full Text] [Related]
2. Oral fluid, a substitute for serum to monitor measles IgG antibody?
Goyal A; Shaikh NJ; Kinikar AA; Wairagkar NS
Indian J Med Microbiol; 2009; 27(4):351-3. PubMed ID: 19736406
[TBL] [Abstract][Full Text] [Related]
3. Determination of measles, mumps, and rubella immunization status using oral fluid samples.
Thieme T; Piacentini S; Davidson S; Steingart K
JAMA; 1994 Jul; 272(3):219-21. PubMed ID: 8022041
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a commercial rubella IgM assay for use on oral fluid samples for diagnosis and surveillance of congenital rubella syndrome and postnatal rubella.
Vijaylakshmi P; Muthukkaruppan VR; Rajasundari A; Korukluoglu G; Nigatu W; L A Warrener ; Samuel D; Brown DW
J Clin Virol; 2006 Dec; 37(4):265-8. PubMed ID: 17049919
[TBL] [Abstract][Full Text] [Related]
5. Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh.
Hayford KT; Al-Emran HM; Moss WJ; Shomik MS; Bishai D; Levine OS
J Virol Methods; 2013 Nov; 193(2):512-8. PubMed ID: 23872267
[TBL] [Abstract][Full Text] [Related]
6. The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella.
Jin L; Vyse A; Brown DW
Bull World Health Organ; 2002; 80(1):76-7. PubMed ID: 11884979
[No Abstract] [Full Text] [Related]
7. Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies.
Talukder Y; Gopal R; Andrews N; Glenn M; Breuer J; Brown D
J Virol Methods; 2005 Sep; 128(1-2):162-7. PubMed ID: 15961168
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys.
Nigatu W; Samuel D; Cohen B; Cumberland P; Lemma E; Brown DW; Nokes J
Vaccine; 2008 Sep; 26(37):4769-74. PubMed ID: 18644417
[TBL] [Abstract][Full Text] [Related]
9. Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA).
Nigatu W; Nokes DJ; Enquselassie F; Brown DW; Cohen BJ; Vyse AJ; Cutts FT
J Virol Methods; 1999 Dec; 83(1-2):135-44. PubMed ID: 10598091
[TBL] [Abstract][Full Text] [Related]
10. A comparison of oral fluid and serum for the detection of rubella-specific antibodies in a community study in Addis Ababa, Ethiopia.
Nokes DJ; Nigatu W; Abebe A; Messele T; Dejene A; Enquselassie F; Vyse A; Brown D; Cutts FT
Trop Med Int Health; 1998 Apr; 3(4):258-67. PubMed ID: 9623926
[TBL] [Abstract][Full Text] [Related]
11. Validation of a modified commercial assay for the detection of rubella-specific IgG in oral fluid for use in population studies.
Ben Salah A; Zaâtour A; Pomery L; Cohen BJ; Brown DW; Andrews N
J Virol Methods; 2003 Dec; 114(2):151-8. PubMed ID: 14625050
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community.
Nokes DJ; Enquselassie F; Vyse A; Nigatu W; Cutts FT; Brown DW
Trans R Soc Trop Med Hyg; 1998; 92(6):679-85. PubMed ID: 10326122
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of young offenders to measles and rubella: an antibody prevalence study using oral fluid samples.
Gill J; Aston R; Vyse AJ; White JM; Greenwood A
Commun Dis Public Health; 2002 Dec; 5(4):314-7. PubMed ID: 12564248
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antibodies to measles and rubella in Sana'a, Yemen.
Sallam TA; Al-Jaufy AY; Al-Shaibany KS; Ghauth AB; Best JM
Vaccine; 2006 Sep; 24(37-39):6304-8. PubMed ID: 16815602
[TBL] [Abstract][Full Text] [Related]
15. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
Kremer JR; Schneider F; Muller CP
Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of commercial assay detecting specific immunoglobulin g in oral fluid for determining measles immunity in vaccinees.
Kremer JR; Muller CP
Clin Diagn Lab Immunol; 2005 May; 12(5):668-70. PubMed ID: 15879031
[TBL] [Abstract][Full Text] [Related]
17. Viral diseases in Ethiopia: a review.
Aseffa A
East Afr Med J; 1993 Oct; 70(10):624-6. PubMed ID: 8187657
[TBL] [Abstract][Full Text] [Related]
18. Oral fluid for the serological and molecular diagnosis of measles.
Hutse V; Van Hecke K; De Bruyn R; Samu O; Lernout T; Muyembe JJ; Brochier B
Int J Infect Dis; 2010 Nov; 14(11):e991-7. PubMed ID: 20851015
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of an antibody capture ELISA for detection of IgG to Epstein-Barr virus in oral fluid samples.
Sheppard C; Cohen B; Andrews N; Surridge H
J Virol Methods; 2001 Apr; 93(1-2):157-66. PubMed ID: 11311354
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots.
Judd A; Parry J; Hickman M; McDonald T; Jordan L; Lewis K; Contreras M; Dusheiko G; Foster G; Gill N; Kemp K; Main J; Murray-Lyon I; Nelson M
J Med Virol; 2003 Sep; 71(1):49-55. PubMed ID: 12858408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
